Alberta Health services: Clinical Trials

23 trials sponsored by Alberta Health services, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

12 completed, 6 unknown, 2 recruiting, 2 terminated. 23 Phase 2, 5 Phase 1, 1 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 223Completed 12, Unknown 6, Recruiting 2, Terminated 2, Withdrawn 1
Phase 15Completed 4, Unknown 1
Phase 31Withdrawn 1

Follow Alberta Health services: new trials by email

Trials (filtered) newest first · largest first

All 23 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Prevention of Nephrotoxin-Induced Acute Kidney Injury Using Cilastatin
Cilastatin Sodium, Placebo-Saline - Acute Kidney Injury
Phase 2RecruitingMatthew James6982025-07-162025-11-26
Sertraline vs. Placebo in the Treatment of Anxiety in Children and AdoLescents With NeurodevelopMental Disorders
Sertraline, Placebo - Neurodevelopmental Disorders, Autism
Phase 2RecruitingHolland Bloorview Kids Rehabilitation Hospital1302024-09-162026-07-27
Sonothrombolysis in Patients With STEMI
Definity, (Lipid Microspheres) Intravenous Suspension, Myocardial Contrast Echocardiography, Repurfusion therapy with PPCI - ST-segment Elevation Myocardial Infarction
Phase 2CompletedHarald Becher152017-08-152021-06-09
Preemptive Therapy of GVHD
rabbit antithymocyte globulin - Graft-vs-host Disease
Phase 2TerminatedUniversity of Calgary702014-01-012023-11-30
Orthomolecular Therapy and Asthma in Children
Orthomolecular Therapy or Placebo Comparator - Asthma
Phase 2UnknownCanadian Institute of Natural and Integrative Medicine902011-02-012011-02-04
Facilitating Physical Activity Behavior and Health Outcomes in Breast Cancer Patients Receiving Chemotherapy
Physical Activity Resource Kit, Standard Materials - Breast Cancer
Phase 2UnknownAthabasca University1502010-08-012011-07-01
Frameless Stereotactic Radiosurgery for Brain Metastases
Frameless Stereotactic Radiosurgery with radiation mask - Brain Metastases
Phase 1 / Phase 2UnknownAlberta Health services202010-01-012011-11-22
Frovatriptan as a Transitional Therapy in Medication Overuse Headache
Frovatriptan, Placebo - Medication Overuse Headache, Analgesic Overuse Headache
Phase 2CompletedUniversity of Calgary552010-01-012019-04-18
Evaluation of the Safety and Effectiveness of Stomaphyx for Transoral Incisionless Reduction of the Enlarged Gastric Pouch and Stoma
StomaphyX - Morbid Obesity
Phase 2CompletedUniversity of Alberta142009-02-012017-03-10
Stereotactic Body Radiation Therapy (SBRT) in the Treatment of Liver Tumors
Stereotactic Body Radiation Therapy - Liver Tumors
Phase 2UnknownAlberta Health services712007-11-012012-01-19
Sutent Maintenance After Response to Taxotere
Sunitinib (SU011248) - Prostate Cancer, Hormone Refractory
Phase 2UnknownAlberta Health services302007-10-012011-12-07
Sublingual Methadone for the Management of Cancer-related Procedure Pain in Inpatients
Sublingual Methadone - Cancer, Pain
Phase 2TerminatedAlberta Health services602006-12-012012-01-19
Orexigenic Therapy With Delta-9-tetrahydrocannabinol in Advanced Cancer Patients With Chemosensory Abnormalities - a Pilot Study
Marinol (Dronabinol), Placebo - Cancer, Anorexia
Phase 2CompletedAlberta Health services802006-08-012010-02-09
Phase II Study of IMRT With SIB as Adjuvant Treatment for High Risk Resected Well-differentiated Thyroid Cancer.
IMRT - Thyroid Neoplasms
Phase 2CompletedAlberta Health services402006-01-012012-01-19
Hypofractionated Radiotherapy (55 Gy/16 Fractions/4 Weeks) for Localized Prostate Cancer
Hypofractionated radiotherapy - Prostate Cancer
Phase 1 / Phase 2CompletedAlberta Health services352004-10-012011-10-10
Short-course Hypofractionated Radiotherapy for Localized Prostate Cancer
radiotherapy - Prostate Cancer
Phase 1 / Phase 2CompletedAlberta Health services722004-09-012012-01-19
Study Using Induction Chemotherapy and Intensity-Modulated Radiation Therapy Guided by Combined CT and PET Imaging for Patients With Non-Small Cell Lung Cancer
Intensity-Modulated Radiation Therapy - Carcinoma, Non-Small-Cell Lung
Phase 1 / Phase 2CompletedAlberta Health services52003-09-012010-02-09
A Trial of Strontium +/- Cisplatin for the Palliation of Bone Pain Secondary to Hormone Refractory Prostate Cancer
strontium-89, cisplatin - Hormone Refractory Prostate Cancer, Bone Metastases
Phase 2CompletedAlberta Health services582003-08-012012-01-19
A Study of Preoperative Radiation Therapy and Capecitabine in Locally Advanced Rectal Cancer
Capecitabine, Pelvic radiation - Rectal Cancer, Neoplasm Metastasis
Phase 2UnknownAlberta Health services662002-01-012012-01-19
Study of 5-FU + Leucovorin + CPT-11 in Patients With Resectable Liver Metastases From Colorectal Adenocarcinoma
perioperative chemotherapy - Colorectal Adenocarcinoma, Liver Metastases
Phase 2CompletedAlberta Health services702002-01-012012-01-19

Showing 20 of 23. Sign in to see all of them.

Conditions studied

Prostatic Neoplasms (4)  ·  Neoplasms (2)  ·  22q11 Deletion Syndrome (1)  ·  Acute Kidney Injury (1)  ·  Anorexia (1)  ·  Anxiety Disorders (1)  ·  Asthma (1)  ·  Attention Deficit Disorder with Hyperactivity (1)  ·  Autism Spectrum Disorder (1)  ·  Autistic Disorder (1)  ·  Brain Neoplasms (1)  ·  Breast Neoplasms (1)  ·  Carcinoma, Hepatocellular (1)  ·  Carcinoma, Non-Small-Cell Lung (1)  ·  DiGeorge Syndrome (1)

Interventions

Radiotherapy, Intensity-Modulated (3)  ·  Capecitabine (1)  ·  Cilastatin (1)  ·  Cisplatin (1)  ·  Dronabinol (1)  ·  Orthomolecular Therapy (1)  ·  Radiation Dose Hypofractionation (1)  ·  Radiosurgery (1)  ·  Radiotherapy (1)  ·  Selective Serotonin Reuptake Inhibitors (1)  ·  Sertraline (1)  ·  Strontium-89 (1)  ·  Sunitinib (1)  ·  frovatriptan (1)  ·  perflutren (1)

Countries

Canada (21)

Top investigators

Jackson Wu (2)  ·  Badri Rickhi, MB,BS,FRCPC (1)  ·  Bernhard Eigl, M.D. (1)  ·  Bernie Eigl, MD (1)  ·  Doug Stewart (1)  ·  Dr. Evdokia Anagnostou (1)  ·  Eric Arrata, ND (1)  ·  Farnaz Amoozegar, MD, FRCPC (1)  ·  Gwyn Bebb, MD (1)  ·  Harald Becher (1)  ·  Harold Lau, MD (1)  ·  Harold P Lau, MD (1)  ·  Hude Quan, MD, PhD (1)  ·  Ingrid H. de Kock, MD (1)  ·  Jan Storek, MD, PhD (1)

Results publications

PMID 19457245, PMID 21343383, PMID 21831743, PMID 22280805, PMID 34373186